Doppler assessment of the fetus in pregnant women recovered from <scp>COVID</scp>‐19

Anuk, Ali Taner; Yetiskin, Fatma Didem Yucel; Buyuk, Gül Nihal; Şenel, Selvi Aydın; Keskin, Hüseyin Levent; Moraloğlu, Özlem; Uygur, Dilek

doi:10.1111/jog.14726

Cited by 18 publications

(16 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although the pathophysiology of SARS-CoV-2 infection in pregnancy has not been absolutely clear, they considered that third-trimester uterine artery measurement with biometric measures is enough to predict the risk of late-onset fetal growth restriction and stillbirth. However, they only found one case of intrauterine growth restriction in the study group [ 23 ] . These controversial results could be due to the difference in the degree of infection included as they include severe cases in their study.…”

Section: Discussionmentioning

confidence: 99%

Assessment of fetal growth and anomalies in the era of COVID-19 pandemic: an Egyptian pilot study

Eltemamy

Salama

Salem

et al. 2021

Middle East Fertil Soc J

View full text Add to dashboard Cite

Background Many issues need to be studied regarding pregnant women during the SARS-CoV-2 (COVID-19) infection pandemic. The aim of this study was to assess fetal growth, fetal well-being, and any observed gross anomalies that may follow SARS-CoV-2 infection in Egyptian pregnant women. During fetal anomaly scan at 22 weeks, we compared 30 pregnant women with a history of SARS-CoV-2 infection at 6‑12 weeks of gestation (group A) with 60 pregnant women (group B) who had no history of SARS-CoV-2. Then, we followed them on 28 and 34 weeks of gestation with fetal biometry and Doppler study. Results Our results revealed no significant difference between both groups regarding fetal biometry, estimated fetal weight, amniotic fluid index, Doppler scan, and gross anomaly scan throughout all visits. Conclusion According to the results of our pilot study, SARS-CoV-2 infection in pregnancy was not found to increase the risk of fetal growth restriction or possible fetal gross anomalies. Nevertheless, larger-scale studies are needed to confirm those findings. Perhaps, post-SARS-CoV-2 infection pregnancies may run an uncomplicated course regarding fetal parameters.

show abstract

Section: Discussionmentioning

confidence: 99%

Assessment of fetal growth and anomalies in the era of COVID-19 pandemic: an Egyptian pilot study

Eltemamy

Salama

Salem

et al. 2021

Middle East Fertil Soc J

View full text Add to dashboard Cite

show abstract

“…No difference was present between healthy pregnant women and those with mild/moderate COVID-19 in terms of fetal Doppler parameters [69]. However, the pulsatility and resistance indices of umbilical and uterine arteries showed a significant increase in pregnant women recovered from COVID-19 compared to the controls [68]. The possible adverse effect of COVID-19 on the feto-placental circulation may be one of the factors behind the increased rates of perinatal complications in these cases.…”

Section: Obstetric and Neonatal Complicationsmentioning

confidence: 80%

“…The possible effect of COVID-19 on fetal Doppler parameters was also investigated in current studies [68,69]. No difference was present between healthy pregnant women and those with mild/moderate COVID-19 in terms of fetal Doppler parameters [69].…”

Section: Obstetric and Neonatal Complicationsmentioning

confidence: 82%

Pregnancy and COVID-19: prevention, vaccination, therapy, and beyond

Şahın¹,

Webster²,

Tekın³

2021

Turk J Med Sci

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19) caused by Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has alarmed the world since its first emergence. As pregnancy is characterized by significant changes in cardiovascular, respiratory, endocrine and immunological systems, there are concerns on issues like the course of disease in pregnant women, safety of medications, route of delivery and risk of obstetric complications. The aim of this review is to summarize the current literature in the management of pregnant women during the COVID-19 pandemic. Although more than 90% of pregnant women with COVID-19 recover without serious morbidity, rapid deterioration of disease and higher rates of obstetric complications may be observed. The risk of vertical transmission has not been clearly revealed, yet. Decreasing the number of prenatal visits, shortening the time allocated for the examinations, active use of telemedicine services, limiting the number of persons in health-care settings, combining prenatal tests in the same visit, restricting visitors during the visits, providing a safe environment in health-care facilities, strict hygene control and providing personal protective equipment during the visits are the main strategies to control the spread of disease according to current guidelines. Although new medication alternatives are being proposed every day for the treatment of COVID-19, our knowledge about the use of most of these drugs in pregnancy is limited. Preliminary results are promising for the administration of SARS-CoV-2 vaccines in the pregnant population. Timing of delivery should be decided based on maternal health condition, accompanying obstetric complications and gestational age. Cesarean delivery should be performed for obstetric indications. Breast feeding should be encouraged as long as necessary precautions for viral transmission are

show abstract

“…Fetal Doppler assessment in COVID‐19 patients is reported to be similar to those in healthy patients, although disagreement exists 23–25 . Furthermore, in COVID‐19 pregnant patients, impaired placental function or Doppler abnormalities seem not to be linked with fetal growth restrictions in second half of pregnancy 9 .…”

Section: Discussionmentioning

confidence: 97%

Acute SARS‐CoV‐2 alpha variant infection leading to placental insufficiency and fetal distress

Dumont

Balduyck

Vanwalleghem

et al. 2021

Journal of Medical Virology

View full text Add to dashboard Cite

The effect of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Alpha variant (also known as B.1.1.7 lineage, 20I/501Y.V1, the UK variant or VOC 202012/01) infection on pregnancy is currently unknown.We present a case of a 37-year-old woman admitted to our tertiary hospital at a gestational age of 29 weeks and 1 day because of oligohydramnios with reduced fetal movements for 10 days. About 20 days before admission, she tested positive for SARS-CoV-2 Alpha variant. The following day, due to abnormal cardiotocography, increased brain sparing, and absent end-diastolic flow in the umbilical artery, an urgent cesarean section was performed. The neonate had an uneventful admission to the neonatal intensive care unit. All neonatal samples proved negative for SARS-CoV-2.Pathological examination of the placenta revealed intervillous fibrin deposition, ischemic necrosis of villi and histiocytic intervillositis, corresponding with the SARS-CoV-2 placentitis triad. The placental tissue demonstrated a high viral load, possibly explaining the acute onset of placental insufficiently and subsequent fetal distress. This case demonstrates the importance of seeking medical care when experiencing reduced fetal movement in SARS-CoV-2 infected patients since acute infection can induce significant placental and subsequent fetal pathology.

show abstract

Doppler assessment of the fetus in pregnant women recovered from COVID‐19

Cited by 18 publications

References 22 publications

Assessment of fetal growth and anomalies in the era of COVID-19 pandemic: an Egyptian pilot study

Assessment of fetal growth and anomalies in the era of COVID-19 pandemic: an Egyptian pilot study

Pregnancy and COVID-19: prevention, vaccination, therapy, and beyond

Acute SARS‐CoV‐2 alpha variant infection leading to placental insufficiency and fetal distress

Contact Info

Product

Resources

About